SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is drawing intense community focus after reports that it plans to monetize excess AI compute capacity through a new cloud offering, a strategic shift that has sparked heated debate over whether it signals genuine revenue diversification or underlying desperation regarding capital expenditure. Traders are actively clashing over the long-term impact on the AI infrastructure ecosystem, as the stock faces volatile price action driven by conflicting narratives about compute scarcity versus potential overcapacity.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing intense selling pressure as investors react to a significant executive compensation package that lacks immediate performance milestones, coupled with broader market volatility in the AI infrastructure sector. The community is deeply divided between long-term bulls who view the current price drop as an aggressive accumulation opportunity and vocal critics who are questioning management's capital allocation and execution speed.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility and aggressive profit-taking, fueling a heated debate among investors about whether this marks a fundamental trend reversal or a healthy correction within the broader semiconductor cycle. While the community remains polarized, many are closely monitoring key support levels to determine if the stock will stabilize or face further downside following its recent parabolic run.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing intense volatility as investors weigh the company's aggressive pivot toward AI infrastructure against the reality of legacy revenue declines and heavy debt. While the community is actively debating the durability of its fiber footprint and the potential for a transformative 'J-curve' revenue inflection, the stock's price action is being heavily driven by mechanical forces like index rebalancing and short-term speculative trading.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is experiencing significant volatility and trading momentum following a 13G filing revealing that Michael Platts BlueCrest Capital Management has taken a 5.6% stake. The community is actively debating whether this institutional interest signals a sustainable growth phase for the company's humanoid robotics ambitions or if the move is merely a short-term catalyst in an otherwise speculative SPAC environment.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as investors debate its pivot toward AI infrastructure and high-performance computing, with sentiment heavily divided by management's strategic communication and dilution concerns. The community is actively discussing the stock's volatility relative to Bitcoin's price movements and the potential for a long-term turnaround based on pending data center tenant deals.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is currently a focal point for investors as the community debates the significance of its recent research agreement with Honda alongside the potential for upcoming manufacturing milestones related to its 'Eagle Line' production. While some market participants are actively adding positions in anticipation of future commercial breakthroughs, others remain vocal about their frustration regarding the stock's stagnant price action and limited revenue generation.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following positive interim Phase 1/2a results for its ARO-INHBE and ARO-ALK7 obesity programs, which demonstrated significant potential as combination therapies to enhance weight and visceral fat loss. The community is actively discussing the clinical data's impact on Arrowhead's long-term valuation and pipeline competitiveness, with many investors debating the company's potential as a major acquisition target.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is seeing heightened volatility and downward pressure as market sentiment shifts toward emerging satellite-based competition, leading some investors to debate the long-term impact of non-terrestrial connectivity versus established fiber infrastructure. While many in the community are expressing frustration over the recent price decline and lack of management commentary, others view the current valuation as an attractive opportunity to accumulate shares for the dividend yield.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as investors monitor the upcoming July 7 PDUFA decision for atacicept, which faces high expectations given strong clinical data in IgA nephropathy. The community is actively debating the competitive landscape versus Otsuka's recently released competitor data, while many shareholders view the recent price volatility as a shakeout before the imminent FDA decision.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UroGen Pharma Reaches Analyst Target Price

In recent trading, shares of UroGen Pharma Ltd (Symbol: URGN) have crossed above the average analyst 12-month target price of $36.88, changing hands for $37.94/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va...

Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares?

Key Points10,000 shares were sold for a transaction value of ~$350,000 at a weighted average price of around $35.01 per share on June 22, 2026...

Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?

Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares...

IBRX and the BCG Shortage: Deals That Could Expand Demand

ImmunityBio targets the BCG shortage with new supply deals and label expansion efforts that could strengthen Anktiva demand in bladder cancer.

What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge

Key PointsSuperstring Capital sold 330,983 shares of UroGen Pharma Ltd last quarter; the estimated transaction value was $6.64 million based on quarterly average pricing...

Urogen Pharma (URGN) Just Flashed Golden Cross Signal: Do You Buy?

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Urogen Pharma (NASDAQ:URGN) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Urogen Pharma (NASDAQ:URGN - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.47) earnings per share for the quarter, topping analysts' consensus estimates of ($0.48) by $0.01. The company had revenue of $50.96 million for the quarter, compared to analyst...

Urogen Pharma (NASDAQ:URGN) Trading Up 14% on Better-Than-Expected Earnings

Urogen Pharma (NASDAQ:URGN) Trading 14% Higher Following Better-Than-Expected Earnings...

Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of +16.44% and +16.96%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of +16.13% and +14.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

UroGen Pharma Ltd

UroGen Pharma Stock Scores Bullish Price Target Revisions Up To $47 Following FDA Nod For Zusduri

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

URGNUroGen Pharma Ltd

Fundamentals

Latest URGN News